New Hepatitis C Treatment

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
The standard treatment for hepatitis C, interferon and ribavirin, cures just 45% of those who receive it. There are now several dozen new drugs for the disease under development, and 2 were approved by the FDA in 2011: telaprevir and boceprevir. The new drugs, which directly attack the virus that causes hepatitis C with minimal impact on the human host, have raised hopes of shorter treatment times and higher cure rates. Researchers are also looking at ways of tailoring treatment to individual patients based on genetic testing.
 
To learn more, check out this video:

Related Articles
From a bad customer service experience, independent musician Dave Carroll learned valuable lessons that apply to independent community pharmacists.
Though the fall semester is underway, it’s not too late to change your studying habits.
Author, speaker, and entrepreneur Guy Kawasaki inspired independent community pharmacists to be enchanting.
Latest Issues
$auto_registration$